Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human ODZ3 ELISA Kit (AC2955)
Cat.#: ASET-1544
Specifications
Description Human ODZ3 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human ODZ3 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 5.16 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 75-1200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2376 Human Stomatin ELISA Kit (AC3787) Quantitative inquiry ASET-1001 Human Apo-D ELISA Kit (AC2412) Quantitative inquiry ASET-2008 Human DIO2 ELISA Kit (AC3419) Quantitative inquiry ASET-1897 Mouse Estrogen Receptor beta ELISA Kit (AC3308) Quantitative inquiry ASET-1988 Rat Pituitary Adenylate Cyclase-Activating Polypeptide ELISA Kit (AC3399) Quantitative inquiry ASET-1054 Human LCN1 ELISA Kit (AC2465) Quantitative inquiry ASET-1130 Mouse Leptin ELISA Kit (AC2541) Quantitative inquiry ASET-1743 Human TMPRSS2 ELISA Kit (AC3154) Quantitative inquiry ASET-1848 Rat Notch2 ELISA Kit (AC3259) Quantitative inquiry ASET-2061 Rat NF-kB p65 ELISA Kit (AC3472) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket